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Abstract
Morphologic evolution of recent small subcortical infarcts (RSSI) ranges from lesion disappearance to lacune formation and the
reasons for this variability are still poorly understood. We hypothesized that diffusion tensor imaging (DTI) and blood-brain-
barrier (BBB) abnormalities early on can predict tissue damage 1 year after an RSSI. We studied prospectively recruited patients
with a symptomatic MRI-defined RSSI who underwent baseline and two pre-specified MRI examinations at 1–3-month and 1-
year post-stroke. We defined the extent of long-term tissue destruction, termed cavitation index, as the ratio of the 1-year T1-
weighted cavity volume to the baseline RSSI volume on FLAIR. We calculated fractional anisotropy and mean diffusivity (MD)
of the RSSI and normal-appearing white matter, and BBB leakage in different tissues on dynamic contrast-enhanced MRI.
Amongst 60 patients, at 1-year post-stroke, 44 patients showed some degree of RSSI cavitation on FLAIR, increasing to 50
on T2- and 56 on T1-weighted high-resolution scans, with a median cavitation index of 7% (range, 1–36%). Demographic,
clinical, and cerebral small vessel disease features were not associated with the cavitation index. While lower baseline MD of the
RSSI (rs = − 0.371; p = 0.004) and more contrast leakage into CSF (rs = 0.347; p = 0.007) were associated with the cavitation
index in univariable analysis, only BBB leakage in CSF remained independently associated with cavitation (beta = 0.315, p =
0.046). Increased BBB leakage into CSF may indicate worse endothelial dysfunction and increased risk of tissue destruction post
RSSI. Although cavitation was common, it only affected a small proportion of the original RSSI.
Keywords Lacunar stroke . Recent small subcortical infarction .MRI . Blood-brain barrier . Diffusion tensor imaging
Introduction
Recent small subcortical infarcts (RSSIs) are the neuroimag-
ing correlate of acute lacunar strokes, which make up to 25%
of all ischemic strokes [1, 2]. RSSIs have different morpho-
logical fates. Besides the classical evolution to a lacunar cav-
ity, they can also turn to a more unspecific lesion (i.e., a non-
cavitated hyperintensity on T2- or FLAIR-weighted MRI
scans) and some vanish after several weeks or months [3–7].
Prior studies have mostly considered FLAIR- and/or T2-
weighted MRI sequences to rate the final tissue outcome of
an RSSI. However, isotropic, high-resolution T1 sequences
increase the sensitivity of detecting small lacunar lesions fol-
lowing an RSSI, yielding some degree of cavitation in > 90%
[3, 5].
The causes and mechanisms that determine the morpholog-
ic evolution of an RSSI are incompletely understood. Factors
leading to more or less tissue destruction would not only be
relevant regarding a more refined understanding of the
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pathophysiology of cerebral small vessel disease (CSVD) but
could also be clinically relevant (e.g., enhance understanding
of the risk of cognitive impairment), since cavitation is likely
to indicate worse tissue destruction than with non-cavitated or
vanishing lesions, and apply to symptomatic and to asymp-
tomatic acute small subcortical lesions [8] that contribute to
accumulating brain damage.
Few studies have assessed the capacity of advanced MRI
techniques to predict tissue destruction following an RSSI. A
promising candidate is diffusion tensor imaging (DTI) by in-
dicating the initial severity of ischemia and of microstructural
(dis)integrity [9]. Another candidate is dynamic contrast-
enhanced (DCE)MRI as increased general blood-brain barrier
(BBB) leakage in subcortical tissues and into CSF has been
seen in patients with more severe microvascular brain changes
[10, 11], and could also be associated with increased focal
morphological damage following an RSSI.
We hypothesized that (1) more severe DTI abnormalities of
the RSSI at baseline and (2) greater BBB leakage 1–3-month
post-stroke on DCE MRI would be associated with more se-
vere focal tissue destruction 1 year after an RSSI. We used a
high-resolution T1 sequence to increase the sensitivity for
detecting cavity formation and quantified the amount of “total
tissue destruction” as the ratio of the T1 cavity volume at year
1 and the FLAIR infarct volume at baseline, which we termed
the cavitation index.
Methods
Data that support the findings of this study are available from
the corresponding author upon reasonable request.
Study Participants
RSSI patients were selected from the prospective observation-
al “Mild Stroke Study 2” (MSS2) that was conducted between
May 1, 2010, andMay 31, 2013. In brief, MSS2 prospectively
recruited ischemic stroke patients who presented to the
Lothian Stroke Service in Edinburgh, UK, with symptoms
of mild stroke (i.e., National Institutes of Health Stroke
Scale score [NIHSS] ≤ 7) including lacunar and cortical sub-
types. All patients had a thorough clinical examination by
dedicated stroke physicians and detailed diagnostic workup
including brain MRI at presentation. All patients were also
invited for a second brain MRI scan at 1–3 month(s) after
stroke to assess BBB leakage on dynamic contrast-enhanced
(DCE) imaging, and for a third MRI at 1 year after stroke to
assess changes in vascular brain lesions. More details of the
MSS2 study have been published previously [12, 13].
For the present study, we considered all MSS2 study par-
ticipants with the following inclusion criteria:
– Stroke symptoms with a compatible MRI-defined RSSI
< 20 mm in axial diameter and located in the supply area
of a small perforating brain artery,
– Availability of 1–3-month MRI including DCE scans to
assess BBB leakage,
– Availability of 1-year MRI for rating of RSSI lesion
change.
Magnetic Resonance Imaging Acquisition
All three MRI examinations were performed on the same
scanner (1.5 T Signa HDxt, General Electric, Milwaukee,
WI), the stability of which was maintained and monitored
under a tight quality assurance program. Diagnostic MRI at
presentation included diffusion tensor imaging (DTI),
FLAIR-, T2-, T2*-, and T1-weighted volume sequences (all
1 mm slice gap). The same sequences were used at 1 year.
Detailed technical information on the MRI protocol is provid-
ed elsewhere [12].
DCE MRI to assess BBB leakage was performed at 1–
3 month(s) after the index stroke to minimize the effect of
the acute stroke lesion on BBB. After two 3D fast spoiled
gradient-echo acquisitions (flip angles 2 and 12°) for pre-
contrast T1 (T10) maps, gadoterate meglumine (Gd-DOTA,
DOTAREM; Guerbet, Paris, France) 0.2 mL/kg (i.e.,
0.1 mmol/kg body weight) was injected at 2 mL/s intrave-
nously via an injection pump and then the 3D T1-weighted
sequence was repeated sequentially 20 times for 24min, using
long acquisition times to detect subtle BBB leak [13–15].
Image Analysis
All image analysis was blinded to patient characteristics, clin-
ical outcomes, and BBB and DTI measures. Additionally, dif-
ferent components of the image analysis were performed by
different individuals to maintain blinding.
MRI Assessment at Baseline
All baseline scans were analyzed for the RSSI and chronic
tissue changes characteristic for cerebral small vessel disease
(CSVD). White matter hyperintensities (WMH), lacunes of
presumed vascular origin, microbleeds, and enlarged
perivascular spaces (PVS) were identified according to the
STRIVE criteria [2] by an experienced neuroradiologist
(JMW). WMH were rated according to the Fazekas scale
[16]; superficial and deep atrophy and perivascular spaces
(PVS) were graded according to previously validated scales
[17, 18].
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Rating and Quantitative Assessment of RSSI Evolution
Tissue outcome of the RSSI at the 1–3-month post-stroke and
1 year post-stroke on MRI was rated by an experienced MRI
reader (TG) using co-registered FLAIR-, T2-, and T1-
weighted sequences. A lacunar cavity was defined as a lesion
with CSF signal intensity on respective MRI scans.
The cavitation index= Cavity volume on T1 at 1 yearRSSI volume on FLAIR at baseline was de-
fined as the primary tissue outcome variable. A similar ap-
proach has previously been used in studies in multiple sclero-
sis to determine the “black hole ratio” (i.e., the proportion of
T2-weighted hyperintense lesions that later developed into
T1-weighted hypointense “black holes”) [19, 20].
Magnetic Resonance Image Processing
Boundaries of the RSSI on the original baseline FLAIR im-
ages were delineated on all slices on which it was visible,
using the software Mango (http://ric.uthscsa.edu/mango/)
and guided by the initial DWI sequence. A “control” region
symmetric to the RSSI in the normal-appearing tissue of the
contralateral hemisphere was also drawn, being careful to
avoid areas of coexisting morphologic damage including
WMH. At 1-year follow-up MRI, T1 hypointensity of the
index RSSI was alsomanually outlined. Identification of these
lesions was guided by concurrent MRI scans. We were careful
to avoid misclassifying a T1 hypointensity as a PVS by
looking at baseline MRI scans (including co-registration).
For inter-rater reliability measurements, cavitation volume at
1 year on T1 as the main tissue outcome parameter was also
outlined and calculated by a second rater (MVH) with differ-
ent professional background (see supplementary material).
Diffusion Analysis
Parametric maps of fractional anisotropy (FA) and mean dif-
fusivity (MD) maps were generated from the DTI acquisition
as described elsewhere [21]. All regions of interest (ROIs)
were mapped from the structural to the diffusion space using
NiftyReg (http://sourceforge.net/projects/niftyreg/) applied
using TractoR software (http://www.tractor-mri.org.uk/
diffusion-processing). In the registration process, we used
trilinear interpolation, preferred in reconstruction algorithms
[22], given the precision required in the space manipulation of
such small ROIs to avoid shape and size distortion. The
resultant ROIs were binarized and, then, multiplied by the
FA and MD maps to calculate the median values of FA and
MD in each ROI. To evaluate the effect of partial volume
effects of the RSSI and “control” ROIs with CSF, the areas
of intersection of these ROIs with a binary mask of CSF in the
diffusion space, generated from a previous study [21], were
removed and median values were also obtained from these
“noCSF” resultant ROIs. MD and FA values of the RSSI
were expressed relative to the contralateral “control” side.
DCE MRI Analysis
The area under the curve (AUC) of the signal enhancement
curves E(t) from t = 0 (administration of contrast agent) to
t = 24 min, which is a semi-quantitative measure of contrast
uptake in tissue, was used as the estimate for BBB leakage.
It was measured separately in CSF, normal-appearing white
and deep gray matter, WMH, and RSSI, which were delin-
eated semiautomatically on co-registered images by an im-
age analyst (MVH) using the in-house developed software
MCMxxxVI (https://sourceforge.net/projects/bric1936/).
All segmented tissue masks were manually checked and
edited as necessary. In order to correct for inter-subject var-
iability of the vascular input, the AUC of the respective
regions of interest was normalized to the AUC of the vas-
cular signal enhancement curve in the superior sagittal sinus
yielding the blood-normalized AUC, as previously reported
[23, 24].
Statistical Analysis
Statistical analyses were performed using the Statistical
Package of the Social Sciences (IBM SPSS Statistics 23).
The level of significance was set at p < 0.05. The
Kolmogorov-Smirnov test and visual inspection of histograms
assessed normality of data distribution. Groups were com-
pared by the chi-square test (for nominal data), Students t test
(for continuous, normally distributed variables), or the Mann–
Whitney U test (for non-normally distributed variables).
Patients were dichotomized according to median split of the
primary outcome variable cavitation index. Correlation anal-
ysis was performed using Spearman correlation.
After logarithmic transformation of the target variable cav-
itation index, we also performed two linear regression analy-
ses based on our pre-specified hypotheses and the results from
univariable analyses. Covariates for the two models were
added on the basis of biological plausibility and a literature
review [3, 4].
Model 1: Cavitation Index and RSSI MD
The first multivariable model for the dependent variable cav-
itation index included patient age, the time interval from
stroke symptom onset to baseline MRI, WMH lesion load
(sum of deep and periventricular WMH scores according to
the Fazekas scale), RSSI size at baseline, and the median MD
value of the RSSI at baseline.
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Model 2: Cavitation Index and BBB Leak in the CSF
The second multivariable model for the target variable cavita-
tion index comprised patient age, the time period from stroke
symptom onset to DCE MRI at 1–3 months, WMH lesion
load, RSSI size, and BBB leakage in the CSF at 1–3-month
post-stroke.
Results
We identified 60 stroke patients (mean age 65.1 ± 10.6 years,
65% male) with a single symptomatic RSSI who fulfilled the
inclusion criteria. DCE MRI data were unavailable in one
patient, therefore 60 patients contributed to cavitation and
DTI, and 59 to BBB analysis. Further clinical and neuro-
imaging characteristics of the study cohort are shown in
Table 1.
At 1-year post-stroke, 44 patients (73%) showed some ev-
idence of cavitation on FLAIR-weighted MRI scans. This
number increased to 50 (83%) when additionally considering
T2-weighted scans. On high-resolution isotropic T1 scans, 56
(93%) patients had some cavitation of the index RSSI (Fig. 1).
The remaining four patients also had small T1 hypointensities,
which became visible after lesion magnification (Fig. 2).
These T1 lesions were included in the calculation of the
Table 1 Baseline clinical andMRI characteristics of the total cohort and comparison of subgroups according to the median split of the cavitation index
Variables Total cohort, n = 60 Cavitation index ≤ 7% Cavitation index > 7% p value
N = 29 N = 31
Age in years, mean (± SD) 65.1 (10.6) 66.1 (9.8) 64.1 (11.4) 0.47
Male sex, n (%) 39 (65) 21 (72) 18 (58) 0.65
NIHSS, median (range) 1 (0–7) 1 (0–5) 1 (0–7) 0.20
Modified Rankin Scale, median (IQR) 1 (2) 1 (1) 2 (2) 0.170
Vascular risk factors, n (%)
Hypertension 46 (77) 26 (84) 20 (69) 0.17
Diabetes 6 (10) 4 (13) 2 (7) 0.44
Hyperlipidemia 39 (65) 20 (65) 19 (66) 0.94
Smoking 24 (40) 12 (39) 12 (41) 0.83
Baseline MRI characteristics
Symptom onset to baseline MRI in days, median (IQR) 4 (4) 4 (5) 4 (3.5) 0.79
Symptom onset to FU 1 MRI in days, median (IQR) 45 (29) 47.5 (28.25) 41 (31) 0.33
Symptom onset to FU 2 MRI in days, median (IQR) 386 (53) 392 (65.25) 384 (49) 0.41
Maximal axial RSSI diameter in mm, median (IQR) 12 (7) 12 (6) 10.5 (7.6) 0.29
RSSI location, n (%) 0.42
Basal ganglia/internal capsule 15 (25) 7 (23) 8 (28)
Centrum semiovale 25 (42) 15 (48) 10 (35)
Thalamus 14 (23) 5 (16) 9 (31)
Brainstem 6 (10) 4 (13) 2 (7)
Fazekas WMH sum score* (0–6), median (IQR) 3 (3) 3.5 (1–6) 3 (2–6) 0.16
Lacunar infarcts ≥ 1, n (%) 30 (50) 16 (52) 14 (48) 0.8
Microbleeds ≥ 1, n (%) 17 (28) 12 (40) 5 (17) 0.054
PVS in basal ganglia (0–4), median (IQR) 2 (2) 2 (1–4) 2 (1–4) 0.97
PVS in centrum semiovale (0–4), median (IQR) 2 (2) 2 (0–4) 2 (1–4) 0.73
Deep atrophy score (0–3), median (IQR) 1 (1) 1 (0–3) 1 (0–3) 0.047
Superficial atrophy score (0–3), median (IQR) 1 (1) 1 (0–3) 1 (0–2) 0.56
Cavitation index at 1 year, median (range) 0.071 (0.01–0.36) 0.045 (0.01–0.07) 0.116 (0.08–0.36) < 0.001
Modified Rankin Scale at 1 year, median (IQR) 1 (1) 1 (2) 1 (1) 0.476
ACE-R [37] at 1 year, median (IQR)# 90 (13) 91.5 (12) 88.5 (15) 0.52
*Sum of periventricular (0–3) and deep (0–3) WMH scores
#Available in 42 patients (n = 22 with cavitation index ≤ 7%; n = 20 with cavitation index > 7%)
SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; FU, follow-up; RSSI, recent small subcortical infarct; PVS, perivascular
spaces; IQR, interquartile range; ACE-R, Addenbrooke’s Cognitive Examination Revised
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cavitation index (subsequent results did not significantly
change after exclusion of these patients).
Median cavitation index at 1-year follow-up was 7%
and ranged from 1 to 36% (median RSSI lesion volume
on FLAIR at baseline 1000 mm3, IQR 942 mm3; median
cavity volume at 1 year on T1 65 mm3, IQR 78 mm3).
Therefore, patients were further dichotomized according
to a cavitation index of ≤ and > 7% (median split,
Table 1) for statistical modeling. Figure 3 shows an ex-
ample of a patient with a cavitation index of 27%. Results
from inter-rater reliability measurements are provided as
online supplementary material; volumetric difference of
the T1 cavity volume at 1 year between the two observers
was 2%.
Cavitation status was not associated with functional neuro-
logical or cognitive outcome at 1 year (Tables 1 and 2).
Predictors of Cavitation
Clinical
There were no associations or correlations between the cavi-
tation index and any of the following: age, sex, baseline clin-
ical characteristics (NIHSS, modified Rankin Scale score, vas-
cular risk factors), or conventional MRI parameters such as
RSSI size and location, or concomitant CSVD burden, indi-
cated by WMH severity, lacunes, PVS, microbleeds, or brain
atrophy (Tables 1 and 2).
DTI
At baseline, median FA and MD levels in normal-appearing
white matter did not correlate with the cavitation index.
Fig. 1 Putaminal RSSI on DWIMRI sequences 2 days after stroke onset (A). At 1-year post-stroke, there is no obvious lesion on FLAIR-weightedMRI
(B, see also magnification in inset), whereas T2- (C) and T1-weighted (D) scans display a small cavity
Fig. 2 Example of an RSSI with subtle cavitation at 1 year. Index RSSI on DWI MRI (A). At 1-year post-stroke, there is no indication for cavitation on
FLAIR- or T2-weighted scans (B and C). Also, T1 shows only subtle cavity formation, which becomes clearer after image magnification (D)
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Median FA and MD levels of the RSSI on baseline MRI were
lower compared with the contralateral control region (FA:
RSSI 0.35 vs. contralateral 0.42, p < 0.001; MD: RSSI 0.73
vs. contralateral 0.77, p < 0.001). After correction for the con-
tralateral control region, baselineMD values of the RSSI were
negatively correlated (rs = − 0.371, p = 0.004) with the cavita-
tion index but there was no correlation between corrected me-
dian FA values of the RSSI and cavitation at 1 year (rs = −
0.084, p = 0.52; Table 2, Fig. 4). In a multivariable linear
regression analysis controlling for age, the time period be-
tween symptom onset to baseline MRI, WMH severity, and
RSSI size on DWI, the median MD value of the RSSI no
longer significantly predicted the cavitation index (beta = −
0.235, p = 0.092).
BBB Leak
There were no correlations between BBB leakage in different
tissues at 1–3-month post-stroke and the cavitation index at
1 year, except for BBB leakage in the CSF, which was asso-
ciated with a higher cavitation index (rs = 0.347, p = 0.007;
Table 2, Fig. 4). In a multivariable linear regression analysis
(controlling for age, the time period between symptom onset
and DCEMRI at 1–3 months, WMH severity, and RSSI size),
increased CSF BBB leakage remained independently posi-
tively associated with cavitation index at 1 year (beta =
0.315, p = 0.046).
Discussion
In this study, nearly all patients with a symptomatic RSSI had
some degree of cavity formation (median amount was 7%,
ranging up to 36% of the original RSSI volume) on high-
resolution, isotropic T1 MRI sequences 1 year after the index
stroke event. To rate the amount of tissue destruction, we
propose the RSSI cavitation index as a quantitative tissue out-
come parameter, which we defined as the ratio of T1 cavity
Fig. 3 Calculation of the RSSI cavitation index. The index RSSI in the
thalamus is segmented on FLAIR scans at baseline (outlined in red). The
green mask illustrates the contralateral control region (image A). Image B
shows the evolution of the RSSI at 1-year follow-up as a cavity on T1.
The cavity was again segmented (displayed in red). The cavitation index
is calculated as the ratio between the volume of the T1 cavity at 1 year and
the FLAIR volume of the RSSI at baseline (= 27% in this case)
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volume at 1-year post-stroke in relation to the RSSI volume on
FLAIR-weighted scans at baseline. While lower MD levels of
the RSSI at baseline MRI (indicating worse initial ischemia)
and BBB leakage in the CSF at 1–3-month post-stroke corre-
lated with a higher cavitation index, only the latter remained
independently associated with the cavitation index in multi-
variable analyses.
Determining predictors for cavitation and the degree of
tissue destruction following an RSSI is important for several
reasons. These include identifying possible differences in tis-
sue vulnerability and repair and a possible underestimation of
brain tissue loss from previous RSSIs on cross-sectional
imaging. Most importantly, the cavity formation after an
RSSI is likely of clinical importance since the volume and
number of lacunes are associated with cognitive decline in
patients with CSVD [25]. In the present study, severity of
cavitation had no effect on functional neurological or general
cognitive outcome at 1-year post-stroke, but notably our sam-
ple was likely not large enough to comprehensively assess
such associations.
In line with most previous studies, we did not find any
associations between baseline demographic, clinical, or con-
ventional MRI features of CSVD with subsequent cavitation
[3, 5–7]. In contrast, another study from our center on a
Table 2 Bivariate correlations of






Age − 0.096 0.47
NIHSS 0.060 0.65
Time stroke symptom onset to MRI at baseline − 0.074 0.58
Time stroke symptom onset to MRI at follow-up 1
(BBB measurements)
− 0.083 0.53
Time stroke symptom onset to MRI at follow-up 2
(rating of tissue outcome)
− 0.203 0.12
RSSI maximal diameter − 0.142 0.28
RSSI volume − 0.140 0.29
WMH periventricular − 0.092 0.49
WMH deep − 0.178 0.18
WMH sum score − 0.137 0.30
Deep atrophy score − 0.210 0.11
Superficial atrophy score − 0.138 0.31
Number of microbleeds − 0.186 0.16
Number of old lacunes 0.118 0.37
DTI parameters at baseline
Median FA of normal-appearing white matter − 0.001 1
Median MD of normal-appearing white matter 0.012 0.93
Median FA of RSSI (corrected for contralateral control region) − 0.084 0.52
Median MD of RSSI (corrected for contralateral control region) − 0.371 0.004
BBB measures at 1–3-month post-stroke*
Normalized AUC CSF 0.347 0.007
Normalized AUC gray matter 0.218 0.10
Normalized AUC white matter 0.080 0.55
Normalized AUC white matter lesions 0.109 0.41
Normalized AUC RSSI − 0.014 0.92
Clinical outcome at 1 year
Modified Rankin scale 0.149 0.26
ACE-R [37] # − 0.067 0.67
*BBB analyses were available in 59 patients (DCE data not available for 1 patient)
# Available in 42 patients
NIHSS, National Institutes of Health Stroke Scale; AUC, area under the curve; RSSI, recent small subcortical
infarct; DTI, diffusion tensor imaging;WMH, white matter hyperintensities;MD, mean diffusivity; FA, fractional
anisotropy; ACE-R, Addenbrooke’s Cognitive Examination Revised
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different cohort using CT or MRI to detect cavitation found
deep brain atrophy was associated with cavitation, and diabe-
tes and hypertension were more frequent in patients with non-
cavitating lesions [4].
The present study suggests that the severity of cavitation is
related to the degree of ischemia in the acute phase of the
infarct since lower MD values of the RSSI (corrected for con-
tralateral control region) correlated with a higher cavitation
index. This finding agrees with a rodent stroke model and a
previous study in patients with territorial ischemia [26, 27].
Likewise, a lower apparent diffusion coefficient (ADC) of the
RSSI has been associated with subsequent RSSI cavitation
(versus no cavitation) in another cohort of patients with lacu-
nar infarction [3]. However, in the present study, theMDvalue
of the RSSI was no longer predictive of cavitation severity
after multivariable analysis. This is again consistent with the
already mentioned study [3] and another investigation [28]
using the ADC to estimate the initial degree of ischemia—
both reports also showed that ADC levels of acute stroke
lesions did not predict subsequent tissue outcome after adjust-
ment for covariates. Moreover, we found no correlation of
lesional FA values with cavitation. This agrees with previous
work showing that FA is less predictive of acute stroke tissue
fate [29] and could be explained by rather heterogeneous FA
patterns in acute cerebral ischemia [30].
Most interestingly, we found that CSF BBB leakage at 1–3-
month follow-up after stroke correlated with the cavitation
index independently. While the present study was small, this
finding supports the role of diffuse widespread endothelial
dysfunction in the pathophysiology of CSVD [31]. In longi-
tudinal studies, BBB leakage predicted recurrent stroke, more
accumulating CSVD changes (progression of WMH), and
cognitive decline in patients with lacunar stroke [11, 13].
Subtle BBB disruption could increase leakage of fibrinogen,
which is toxic in interstitial tissues, increasing perivascular
inflammation/immune activation and inducing neurodegener-
ation and progressive CSVD-related brain damage [13, 32].
The finding of increased levels of the neurofilament light
chain protein (NfL) in the serum of RSSI patients with subse-
quent lesion cavitation could support this assumption [3].
While such an increase most likely comes from more exten-
sive neuroaxonal damage [33], a leaky BBB could also
Fig. 4 Correlation of the cavitation index with RSSI mean diffusivity (a) and fractional anisotropy (b), and BBB leakage in the CSF (normalized AUC of
the signal enhancement curve on dynamic contrast-enhanced MRI, c)
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facilitate the release of NfL into the blood. However, we also
have to note that BBB leakage in other cerebral tissues was not
associated with cavitation. This could potentially also be ex-
plained by the applied method, which might not be sensitive
enough to detect more subtle BBB leakage in different paren-
chymal brain tissues.
In previous neuroimaging studies, there is heterogeneity
regarding the morphological evolution of an RSSI.
Depending on the (1) definition of a lacune/cavity, (2) applied
neuroimaging modalities (CT or MRI) and MRI sequences,
and (3) considered follow-up time periods, the rate of cavita-
tion has been reported within a wide range between 48 and
94% [3–7]. Our study is in line with two previous reports
showing that the incorporation of high-resolution T1 se-
quences significantly increases the sensitivity of detecting (of-
ten small) RSSI cavitation [3, 5]. While evidence for lacunar
cavitation was present in nearly three-fourths on FLAIR and
85% on T2, almost all patients (93%) had a visible cavity on
high-resolution T1, a number, which corresponds well with
the study fromMoreau and colleagues reporting cavitation on
T1 sequences in 94% of patients at 90 days after the index
infarct [5]. When we used co-registration and lesion magnifi-
cation and neglected the widely used minimal lacunar diame-
ter of 3 mm [2], we noticed that all patients had at least a small
T1 hypointense lesion at 1-year follow-up MRI. Hence, the
cavitation index was introduced to quantify the amount of
complete tissue destruction. Previous studies only considered
any cavitation versus non-cavitation but not the actual amount
of tissue damage. Besides statistical advantages, our approach
offers the possibility of quantifying the degree of cavitation in
relation to the index stroke lesion. The cavitation index is
similar to the “black hole ratio” used in multiple sclerosis to
assess rates of tissue destruction and ongoing disease activity
[23, 34, 35]. Our study also benefitted from the prospective
recruitment of consecutive stroke patients, a thorough clinical
workup and uniform, pre-specified MRI protocols at given
time points on the same scanner.
We also have to consider several limitations. First, sample
size was moderate, which potentially also limits the explana-
tory power of multivariable analyses. On the other hand, this
is the largest study that has analyzed tissue outcome on RSSI
in detail. Although MRI ratings have been performed without
knowledge of clinical data and most MRI features were avail-
able from prior analyses, RSSI fate was rated by one single
rater. However, inter-rater reliability measurements between
two observers with different experiences and different
methods revealed consistent results regarding cavitation
volume—the main tissue outcome parameter of this study.
Of note, T1 lesions were often small and therefore difficult
to distinguish from enlarged perivascular spaces. However,
while it is possible that some cavities represent residua of a
perivascular space, we took particular care to avoid such mis-
classification with reference to baseline images. Moreover,
exclusion of the four patients without an obvious T1 cavity
did not significantly change the overall results. Irrespective of
that, most of the RSSI tissue does not develop actual cavita-
tion on T1 but remains hyperintense (or regains normal signal)
on FLAIR and T2 sequences [36]. In future analyses, we will
analyze DTI and BBB parameters in RSSI subregions that do
or do not cavitate—an approach, which may help to under-
stand the pathological processes in CSVD, tissue vulnerabili-
ty, and repair. Finally, future studies should also examine in
detail the clinical and especially cognitive domain-specific
(long-term) consequences of more severe tissue destruction
after an RSSI in larger cohorts.
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